These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7926473

  • 1. Flumazenil for hepatic coma: the elusive wake-up call?
    Sterling RK, Shiffman ML, Schubert ML.
    Gastroenterology; 1994 Oct; 107(4):1204-5. PubMed ID: 7926473
    [No Abstract] [Full Text] [Related]

  • 2. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis.
    Goulenok C, Bernard B, Cadranel JF, Thabut D, Di Martino V, Opolon P, Poynard T.
    Aliment Pharmacol Ther; 2002 Mar; 16(3):361-72. PubMed ID: 11876688
    [Abstract] [Full Text] [Related]

  • 3. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G, Di Lorenzo G, Soldini M, Marziali M, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Barbarini G.
    Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
    [Abstract] [Full Text] [Related]

  • 4. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF, el Younsi M, Pidoux B, Zylberberg P, Benhamou Y, Valla D, Opolon P.
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
    Van der Rijt CC, Schalm SW, Meulstee J, Stijnen T.
    Gastroenterol Clin Biol; 1995 Apr; 19(6-7):572-80. PubMed ID: 7590022
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Barbarini G.
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [Abstract] [Full Text] [Related]

  • 9. Flumazenil and hepatic encephalopathy.
    Klotz U, Walker S.
    Lancet; 1989 Jan 21; 1(8630):155-6. PubMed ID: 2563065
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of acute hepatic encephalopathy with flumazenil].
    Viel E, de La Coussaye JE, Bassoul B, Saissi G, Eledjam JJ.
    Ann Fr Anesth Reanim; 1990 Jan 21; 9(4):386-9. PubMed ID: 2119157
    [Abstract] [Full Text] [Related]

  • 11. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
    Péroux JL, Paolini O, Tran A, Frappa B, Rampal P.
    Gastroenterol Clin Biol; 1996 Feb 21; 20(1):106-8. PubMed ID: 8734316
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
    Als-Nielsen B, Kjaergard LL, Gluud C.
    Cochrane Database Syst Rev; 2001 Feb 21; (4):CD002798. PubMed ID: 11687160
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
    Bello Mimbrera G, García de León M, de la Torre Gutiérrez S, Montero Vázquez J, Torres Salcines J, de la Torre Fernández JM.
    Rev Esp Enferm Apar Dig; 1989 Mar 21; 75(3):277-9. PubMed ID: 2499914
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of hepatic encephalopathy with flumazenil].
    Marsepoil T, Hermant JL, Ho P, Blin F, Levesque P.
    Ann Fr Anesth Reanim; 1990 Mar 21; 9(4):399-400. PubMed ID: 2119158
    [No Abstract] [Full Text] [Related]

  • 18. Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial.
    Groeneweg M, Gyr K, Amrein R, Scollo-Lavizzari G, Williams R, Yoo JY, Schalm SW.
    Electroencephalogr Clin Neurophysiol; 1996 Jan 21; 98(1):29-34. PubMed ID: 8689991
    [Abstract] [Full Text] [Related]

  • 19. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study.
    Amodio P, Marchetti P, Del Piccolo F, Beghi A, Comacchio F, Carraro P, Campo G, Baruzzo L, Marchiori C, Gatta A.
    Clin Physiol; 1997 Sep 21; 17(5):533-9. PubMed ID: 9347201
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.